Skip to main content
Top
Published in: European Journal of Nutrition 1/2022

Open Access 01-02-2022 | Insulins | Original Contribution

The female mouse is resistant to mild vitamin B3 deficiency

Authors: Inge van der Stelt, Wenbiao Shi, Melissa Bekkenkamp-Grovenstein, Rubén Zapata-Pérez, Riekelt H. Houtkooper, Vincent C. J. de Boer, Maria A. Hegeman, Jaap Keijer

Published in: European Journal of Nutrition | Issue 1/2022

Login to get access

Abstract

Purpose

Vitamin B3 provides nicotinamide adenine dinucleotide (NAD+), an essential coenzyme in oxidoreductase reactions. Severe vitamin B3 deficiency leads to the disease Pellagra, while mild vitamin B3 deficiency has been linked to age-related and metabolic diseases. Mild vitamin B3 deficiency is understudied, especially in females. Therefore, we examined how female mice responded to a diet that induced mild vitamin B3 deficiency in male mice.

Methods

Female C57BL/6RccHsd mice were subjected for 18 weeks to a diet without vitamin B3 and low but sufficient tryptophan (0.115%) (0NR) and were compared to control female mice on the same diet with the reference dose of vitamin B3 (30NR, 30 mg nicotinamide riboside/ kg diet).

Results

In the female mice, no differences between the two dietary groups were found in liver nicotinamide mononucleotide (NMN) levels, body composition, whole body energy and substrate metabolism measured by indirect calorimetry, or liver triacylglycerol metabolism. Expression of seven genes that previously were shown to respond to mild vitamin B3 deficiency in male white adipose tissue were not differentially expressed between the female dietary groups, neither was insulin sensitivity.

Conclusion

We concluded that the female 0NR mice were not vitamin B3 deficient; the role of age, sex and health status is discussed. Demonstrated by clear differences between females and males, the latter showing mild deficiency under the same conditions, this study highlights the importance of studying both sexes.
Appendix
Available only for authorised users
Literature
8.
go back to reference Grundy SM, Mok HY, Zech L, Berman M (1981) Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 22(1):24–36CrossRef Grundy SM, Mok HY, Zech L, Berman M (1981) Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 22(1):24–36CrossRef
11.
go back to reference Elvehjem CA, Madden RJ, Strong FM, Woolley DW (1937) Relation of nicotinic acid and nicotinic acid aminde to canine black tongue. J Am Chem Soc 59:1767–1768CrossRef Elvehjem CA, Madden RJ, Strong FM, Woolley DW (1937) Relation of nicotinic acid and nicotinic acid aminde to canine black tongue. J Am Chem Soc 59:1767–1768CrossRef
12.
go back to reference Goldberger J (1918) Pellagra: its nature and prevention. Public Health Rep 33(14):481–488CrossRef Goldberger J (1918) Pellagra: its nature and prevention. Public Health Rep 33(14):481–488CrossRef
15.
go back to reference Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281(31):21745–21754. https://doi.org/10.1074/jbc.M602909200CrossRefPubMed Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281(31):21745–21754. https://​doi.​org/​10.​1074/​jbc.​M602909200CrossRefPubMed
41.
go back to reference Sambeat A, Ratajczak J, Joffraud M, Sanchez-Garcia JL, Giner MP, Valsesia A, Giroud-Gerbetant J, Valera-Alberni M, Cercillieux A, Boutant M, Kulkarni SS, Moco S, Canto C (2019) Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage. Nat Commun 10:1–11. https://doi.org/10.1038/s41467-019-12262-x CrossRef Sambeat A, Ratajczak J, Joffraud M, Sanchez-Garcia JL, Giner MP, Valsesia A, Giroud-Gerbetant J, Valera-Alberni M, Cercillieux A, Boutant M, Kulkarni SS, Moco S, Canto C (2019) Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage. Nat Commun 10:1–11. https://​doi.​org/​10.​1038/​s41467-019-12262-x CrossRef
Metadata
Title
The female mouse is resistant to mild vitamin B3 deficiency
Authors
Inge van der Stelt
Wenbiao Shi
Melissa Bekkenkamp-Grovenstein
Rubén Zapata-Pérez
Riekelt H. Houtkooper
Vincent C. J. de Boer
Maria A. Hegeman
Jaap Keijer
Publication date
01-02-2022
Publisher
Springer Berlin Heidelberg
Keywords
Insulins
Insulins
Published in
European Journal of Nutrition / Issue 1/2022
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02651-8

Other articles of this Issue 1/2022

European Journal of Nutrition 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.